Pivot Biotech develops computational tools to accelerate antibody discovery for immunotherapy. The team, spun from UNSW's Biomedical Engineering lab, combines directed evolution algorithms with high-throughput screening to reduce development cycles from years to months. They're working with two leading pharma CROs on early-stage validation.